New breathing tech aims to free ICU patients from ventilators faster

NCT ID NCT05219643

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether a newer breathing support method called NAVA helps patients with ARDS come off mechanical ventilation faster than standard PSV. 130 tracheotomy patients were randomly assigned to one of the two methods. The main goal was to see how many days patients were alive and free from the ventilator within 28 days.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

NAVA (neurally-adjusted ventilatory assist) device

What this could lead to

If successful, NAVA could become a standard method to help patients with ARDS breathe on their own faster, reducing time on a ventilator.

What could go wrong

This is a completed trial with 130 participants, so results are limited. NAVA may not improve weaning success or ICU outcomes compared to standard care.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ARDS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

acute respiratory distress syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Yijishan Hospital, The First Affiliated Hospital of Wannan Medical College

    Wuhu, Anhui, 241001, China

  • Zhongda Hospital

    Nanjing, Jiangsu, 210009, China